Constrictive pericarditis laboratory findings

Constrictive Pericarditis Microchapters
Home
Patient Information
Overview
Historical Perspective
Pathophysiology
Causes
Differentiating Constrictive Pericarditis from other Diseases
Epidemiology and Demographics
Risk Factors
Screening
Natural History, Complications, and Prognosis
Diagnosis
Diagnostic Study of Choice
History and Symptoms
Physical Examination
Laboratory Findings
Electrocardiogram
X-ray
Echocardiography and Ultrasound
CT scan
MRI
Other Imaging Findings
Other Diagnostic Studies
Treatment
Medical Therapy
Surgery
Primary Prevention
Secondary Prevention
Future or Investigational Therapies
Case Studies
Case #1
Constrictive pericarditis laboratory findings On the Web
Most recent articles
Most cited articles
Review articles
CME Programs
Powerpoint slides
Google Images
American Roentgen Ray Society Images of Constrictive pericarditis laboratory findings All Images X-rays Echo & Ultrasound CT Images MRI
Ongoing Trials at Clinical Trials.gov
US National Guidelines Clearinghouse
NICE Guidance
FDA on Constrictive pericarditis laboratory findings
CDC on Constrictive pericarditis laboratory findings
Constrictive pericarditis laboratory findings in the news
Blogs on Constrictive pericarditis laboratory findings
Directions to Hospitals Treating Type page name here
Risk calculators and risk factors for Constrictive pericarditis laboratory findings

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Huda A. Karman, M.D.

Overview

Constrictive pericarditis lab findings can show evidence of congestive heart failure, or associated protein losing enteropathy, nephrotic syndrome, and LFT abnormalities consistent with hepatic congestion and chylous ascites

Laboratory findings

• Complete blood count (CBC)
  • Dilutional anemia if congestive heart failure (CHF) is present
  • Normocytic normochromic anemia (chronic inflammation)
• Leukocytosis
  • Infectious, bacterial, or rheumatologic etiology source or steroid therapy
• Leukopenia
  • Malignancy and chemotherapeutic agents use
• Hyponatremia or pseudohyponatremia
• Contraction alkalosis (hypochloremia with hypercarbia)
• Elevation of blood urea nitrogen (BUN) levels f
• Serum creatinine levels are observed
• Arterial blood gas measurement
• Metabolic acidosis (ie, low pH and low bicarbonate),
• Compensatory respiratory alkalosis (ie, decreased partial pressure of carbon dioxide
• Elevated transaminase levels
• Hypoalbuminemia (a protein-losing enteropathy (PLE)
• Proteinuria (nephrotic range)
• Elevated sedimentation rate (ESR), C-reactive protein (CRP) level (postpericardiotomy syndrome)
• Brain natriuretic peptide (BNP), mildly increased (<150 ng/L)
• Antinuclear antibody (ANA) or rheumatoid factor (RF) (associated collagen vascular disorder)
• Purified protein derivative (PPD) skin test (TB)